Security key
G6724L116
OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO)
CUSIP: G6724L116
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Ordinary Shares, no par value
- Total 13F shares
- 2,075,082
- Total 13F value
- $2,634,954
- Share change
- +1,048,903
- SEC-reported price per share
- $1.27
- Number of holders
- 7
- Value change
- +$1,447,536
- Number of buys
- 3
- Number of sells
- 3
- Shares outstanding
- 52,174,143
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
7
Top holders
7
OKYO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
OKYO Pharma Ltd SEC filings
OKYO Pharma Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP G6724L116
Recent filing periods:
Ownership snapshot
Top reported holders of OKYO - OKYO Pharma Ltd - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BARCLAYS PLC
Disclosed value leader
BARCLAYS PLC
Comparable rows
7/7
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 1.8%
Showing 1-6 of 7 holder rows.
Quick read
BARCLAYS PLC leads the comparable SEC ownership view at 1.8%.
7 of 7 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BARCLAYS PLC's linked filing trail.
Comparable ownership
Top 5
BARCLAYS PLC
1.8%
CITADEL ADVISORS LLC
0.04%
RENAISSANCE TECHNOLOGIES LLC
0.03%
Cerity Partners LLC
0.02%
GEODE CAPITAL MANAGEMENT, LLC
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 7 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BARCLAYS PLC |
13F
Company
|
1.8%
|
$1,105,054
961,000 shares
|
— | 31 Dec 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.04%
|
$23,838
20,729 shares
|
— | 31 Dec 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.03%
|
$18,973
16,500 shares
|
— | 31 Dec 2024 |
| Cerity Partners LLC |
13F
Company
|
0.02%
|
$14,733
12,812 shares
|
— | 31 Dec 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.02%
|
$13,903
12,090 shares
|
— | 31 Dec 2024 |
| UBS Group AG |
13F
Company
|
0.01%
|
$3,448
2,998 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
2,075,082
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2026 Across Filers
Q1 2026 holders
12
Q1 2025 holders
7
Holder diff
-5
| Investor | Q1 2026 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend